PGx Highlights from American College of Cardiology Annual Meeting
April 04, 2012
PGx Highlights from American College of Cardiology Annual Meeting
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Study: Higher Plavix Dose Doesn't Improve Response for CYP2C19*2 Carriers; Effient May Be Best Option
April 4, 2012 / Pharmacogenomics Reporter - Study Points to Role of ABCB1 Gene Alterations in Plavix-Treated Patients' Cardiovascular AEs
March 17, 2010 / Pharmacogenomics Reporter - As BG Medicine Submits Cardio Risk Test to FDA, Some Pharmas See Opportunity for Preventive Therapy
January 11, 2012 / Pharmacogenomics Reporter - Bypassing Phosphorylation, Vandy Team Gauges Kinase Inhibitor Response via Protein Expression Levels
December 9, 2011 / ProteoMonitor - Next-Gen Sequencing: Hot as a Research Tool; Not for Qiagen's Companion Dx Strategy
July 20, 2011 / Pharmacogenomics Reporter